578 related articles for article (PubMed ID: 22269678)
41. Boston keratoprosthesis type I in the elderly.
Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
[TBL] [Abstract][Full Text] [Related]
42. The Boston keratoprosthesis in herpetic keratitis.
Khan BF; Harissi-Dagher M; Pavan-Langston D; Aquavella JV; Dohlman CH
Arch Ophthalmol; 2007 Jun; 125(6):745-9. PubMed ID: 17562983
[TBL] [Abstract][Full Text] [Related]
43. Visual and clinical outcomes of explantation versus preservation of the intraocular lens during keratoprosthesis implantation.
Utine CA; Tzu J; Dunlap K; Akpek EK
J Cataract Refract Surg; 2011 Sep; 37(9):1615-22. PubMed ID: 21855761
[TBL] [Abstract][Full Text] [Related]
44. Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia.
Bakhtiari P; Chan C; Welder JD; de la Cruz J; Holland EJ; Djalilian AR
Am J Ophthalmol; 2012 May; 153(5):967-971.e2. PubMed ID: 22265154
[TBL] [Abstract][Full Text] [Related]
45. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
[TBL] [Abstract][Full Text] [Related]
46. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study.
Akpek EK; Harissi-Dagher M; Petrarca R; Butrus SI; Pineda R; Aquavella JV; Dohlman CH
Am J Ophthalmol; 2007 Aug; 144(2):227-231. PubMed ID: 17543875
[TBL] [Abstract][Full Text] [Related]
47. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
Shah KJ; Cheung AY; Holland EJ
Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
[TBL] [Abstract][Full Text] [Related]
48. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
Geoffrion D; Harissi-Dagher M
Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
[TBL] [Abstract][Full Text] [Related]
49. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.
Hassanaly SI; Talajic JC; Harissi-Dagher M
Am J Ophthalmol; 2014 Aug; 158(2):270-276.e1. PubMed ID: 24844976
[TBL] [Abstract][Full Text] [Related]
50. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
Li J; Yu L; Deng Z; Wang L; Sun L; Ma H; Chen W
Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
[TBL] [Abstract][Full Text] [Related]
51. Cost-effectiveness of the Boston keratoprosthesis.
Ament JD; Stryjewski TP; Ciolino JB; Todani A; Chodosh J; Dohlman CH
Am J Ophthalmol; 2010 Feb; 149(2):221-228.e2. PubMed ID: 19939347
[TBL] [Abstract][Full Text] [Related]
52. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.
Robert MC; Pomerleau V; Harissi-Dagher M
Br J Ophthalmol; 2013 May; 97(5):573-7. PubMed ID: 23435225
[TBL] [Abstract][Full Text] [Related]
53. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
Chan CC; Holland EJ
Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
[TBL] [Abstract][Full Text] [Related]
54. Boston keratoprosthesis outcomes and complications.
Chew HF; Ayres BD; Hammersmith KM; Rapuano CJ; Laibson PR; Myers JS; Jin YP; Cohen EJ
Cornea; 2009 Oct; 28(9):989-96. PubMed ID: 19724214
[TBL] [Abstract][Full Text] [Related]
55. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
[TBL] [Abstract][Full Text] [Related]
56. Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in Boston keratoprosthesis type 1.
Kanellopoulos AJ; Asimellis G
Cornea; 2014 Sep; 33(9):914-8. PubMed ID: 25014143
[TBL] [Abstract][Full Text] [Related]
57. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
[TBL] [Abstract][Full Text] [Related]
58. Boston type 1 keratoprosthesis for failed keratoplasty.
Hager JL; Phillips DL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
Int Ophthalmol; 2016 Feb; 36(1):73-78. PubMed ID: 25975459
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.
Kim MK; Lee SM; Lee JL; Chung TY; Kim YH; Wee WR; Lee JH
Cornea; 2007 Jun; 26(5):546-51. PubMed ID: 17525649
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
